False negative newborn screen and neonatal cholestasis in a premature child with cystic fibrosis

Heidendael, J.; Tabbers, M.; Vreede, I.
December 2014
European Journal of Pediatrics;Dec2014, Vol. 173 Issue 12, p1581
Academic Journal
Newborn screening for cystic fibrosis enables early diagnosis and treatment, leading to better outcomes for patients with cystic fibrosis. Although the sensitivity of several screening protocols is high, false negative screening results of the newborn patient still occur, which can lead to a significant delay in diagnosis when the awareness for presenting symptoms of cystic fibrosis declines. Neonatal cholestasis is one of the presenting symptoms of cystic fibrosis but can be easily missed when total parenteral nutrition has been given. Premature newborns are probably more at risk of a missed underlying diagnosis than term babies because their co-pathologies and management are often more complex. We present a case of a 10-week-old premature boy with a false negative newborn screening for cystic fibrosis, in whom cystic fibrosis presented with neonatal cholestasis. In this case, the immunoreactive trypsinogen/pancreatitis-associated protein/35 cystic fibrosis transmembrane regulator mutation analysis/sequencing method was used. Furthermore, an overview of the literature on missed diagnosis of cystic fibrosis due to a false negative newborn screen is provided. Conclusion: Cystic fibrosis (CF) should be considered in infants with neonatal cholestasis even when the newborn screening for CF is reported to be negative.


Related Articles

  • Lessons learned from 20 years of newborn screening for cystic fibrosis. Massie, R. John H.; Curnow, Lisette; Glazner, Judith; Armstrong, David S.; Francis, Ivan // Medical Journal of Australia;1/16/2012, Vol. 196 Issue 1, p67 

    The article discusses a study on three cystic fibrosis (CF) newborn screening strategies conducted in Victoria since 1989. It note that CF newborn screening determines immunoreactive trypsinogen (IRT) levels in collected dried blood spots. Strategies at issue are repeat IRT testing,...

  • Diagnosing cystic fibrosis: what are we sweating about? Simmonds, Nicholas J.; Bush, Andrew // Thorax;Jul2012, Vol. 67 Issue 7, p571 

    The article discusses the concerns relating to diagnosis of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. It provides information on functions of CFTR which includes encoding a cAMP activated chloride channel and regulating transepithelial ion movement. It focuses on...

  • Age of Diagnosis and the Clinical Phenotypes of Adult Patients With Cystic Fibrosis. Paschoal, Ilma Aparecida; Pereira, Mônica Corso // Annals of Respiratory Medicine;2011, Vol. 3 Issue 1, p1 

    INTRODUCTION Despite being a monogenic disease, Cystic Fibrosis has always been considered a clinical syndrome that may involve multiple organs. Over the past decades survival has improved and currently the median survival is approximately 38 years. Also, it is now recognized that there are...

  • Nasal Potential Difference in Cystic Fibrosis considering Severe CFTR Mutations. Ng, Ronny Tah Yen; Marson, Fernando Augusto de Lima; Ribeiro, Jose Dirceu; Ribeiro, Antonio Fernando; Bertuzzo, Carmen Silvia; Ribeiro, Maria Angela Gonçalves de Oliveira; Severino, Silvana Dalge; Sakano, Eulalia // Disease Markers;1/15/2015, p1 

    The gold standard for diagnosing cystic fibrosis (CF) is a sweat chloride value above 60 mEq/L. However, this historical and important tool has limitations; other techniques should be studied, including the nasal potential difference (NPD) test. CFTR gene sequencing can identify CFTR...

  • Saliva as a potential tool for cystic fibrosis diagnosis. Gonçalves, Aline Cristina; de Lima Marson, Fernando Augusto; de Holanda Mendonça, Regina Maria; Ribeiro, José Dirceu; Ribeiro, Antonio Fernando; Paschoal, Ilma Aparecida; Levy, Carlos Emílio // Diagnostic Pathology;2013, Vol. 8 Issue 1, Special section p1 

    Background: Saliva and sweat are modified by cystic fibrosis (CF). In both cases the chloride and sodium ion concentrations for healthy subjects and CF patients differ, this representing a possible alternative tool for CF diagnosis. In this context, the aim of this study was to compare the...

  • Defective CFTR Expression and Function Are Detectable in Blood Monocytes: Development of a New Blood Test for Cystic Fibrosis. Sorio, Claudio; Buffelli, Mario; Angiari, Chiara; Ettorre, Michele; Johansson, Jan; Vezzalini, Marzia; Viviani, Laura; Ricciardi, Mario; Verzè, Genny; Assael, Baroukh Maurice; Melotti, Paola // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: Evaluation of cystic fibrosis transmembrane conductance regulator (CFTR) functional activity to assess new therapies and define diagnosis of cystic fibrosis (CF) is cumbersome. It is known that leukocytes express detectable levels of CFTR but the molecule has not been characterized...

  • Two cases of chronic pancreatitis associated with anomalous pancreaticobiliary ductal union and SPINK1 mutation. Eun Sam Rho; Earl Kim; Hong Koh; Han-Wook Yoo; Beom Hee Lee; Gu-Hwan Kim // Korean Journal of Pediatrics;May2013, Vol. 56 Issue 5, p227 

    Chronic pancreatitis is a progressive inflammatory disease resulting from repeated episodes of acute pancreatitis that impair exocrine function and eventually produce endocrine insufficiency. Some causes of chronic pancreatitis appear to be associated with alterations in the serine-protease...

  • Maybe That Pancreatitis Isn't So Idiopathic After All. Gilchrist, Dawna // Canadian Journal of General Internal Medicine;Summer2012, Vol. 7 Issue 2, p39 

    The article focuses on the genetic etiology of pancreatitis. It presents three cases on acute and chronic pancreatitis. It discusses several types of genes associated to pancreatitis including protease, serine 1(trypsin 1) (PRSS1), or the cationic trypsinogen, cystic fibrosis transmembrane...

  • CFTR is an essential component in cAMP-dependent granular priming in human and mouse β-cells insulin secretion. Edlund, A.; Esguerra, J. L.; Flodstrom-Tulberg, M.; Eliasson, L. // Proceedings of the Physiological Society;2013, p761P 

    Aim: Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel and regulator of proteins¹. Mutations in CFTR cause cystic fibrosis (CF) and a major complication of CF is diabetes². It is largely unknown why these patients develop diabetes but there is increasing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics